US Drug Recall Register

FDA Drug Recalls

2,661 recalls, newest first

Class III · Low risk Ongoing

Benzonatate Capsules

Reason Superpotent drug: Assay results were slightly above specification at the time zero point.

Amerisource Health Services LLC NDC 68084-214-01 D-0257-2024
Class I · High risk Ongoing

Bleomycin for Injection

Reason Presence of particulate matter: glass

Pfizer NDC 61703-332-18 D-0261-2024
Class I · High risk Ongoing

Atropine Sulfate Injection

Reason Presence of Particulate Matter; identified as glass

Pfizer Inc. NDC 0409-4911-11 D-0235-2024
Class I · High risk Ongoing

8.4 % Sodium Bicarbonate Injection

Reason Presence of Particulate Matter; identified as glass

Pfizer Inc. NDC 0409-6637-24 D-0234-2024
Class I · High risk Ongoing

4.2% Sodium Bicarbonate Injection

Reason Presence of Particulate Matter; identified as glass

Pfizer Inc. NDC 0409-5534-24 D-0233-2024
Class II · Moderate risk Ongoing

Good Neighbor Pharmacy

Reason MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.

Pharma Nobis LLC NDC 46122-741-38 D-0227-2024
Class II · Moderate risk Ongoing

Selenium Sulfide 2.25% Shampoo

Reason CGMP Deviations: Stability data does not support expiry date.

Private Label Partners, Inc. NDC 42582-900-06 D-0152-2024
Class II · Moderate risk Ongoing

Sertraline Tablets

Reason CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.

Legacy Pharmaceutical Packaging LLC NDC 68645-523-54 D-0205-2024
Class II · Moderate risk Ongoing

Nystatin 150 Mu

Reason Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Fagron, Inc NDC 51552-0041-1 D-0157-2024
Class II · Moderate risk Ongoing

Nystatin 2 Bu

Reason Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Fagron, Inc NDC 51552-0041-4 D-0156-2024
Class II · Moderate risk Ongoing

Nystatin 500 Mu

Reason Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Fagron, Inc NDC 51552-0041-3 D-0155-2024
Class II · Moderate risk Ongoing

Nystatin 5bu

Reason Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Fagron, Inc NDC 51552-0041-5 D-0154-2024
Class I · High risk Ongoing

Magnum XXL 9800

Reason Marketed without an approved NDA/ANDA: Magnum XXL found to contain undeclared active pharmaceutical ingredient (API) - Sildenafil.

Meta Herbal D-0206-2024
Class I · High risk Ongoing

SANDIMMUNE Oral Solution

Reason Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals

Novartis Pharmaceuticals Corporation NDC 0078-0110-22 D-0144-2024
Class I · High risk Ongoing

Up&Up brand dry eye relief

Reason Non-Sterility

Kilitch Healthcare India Limited NDC 76168-800-30 D-0311-2024
Class I · High risk Ongoing

Lubricant Eye Drops

Reason Non-Sterility

Kilitch Healthcare India Limited NDC 11822-4811-3 D-0309-2024
Class I · High risk Ongoing

Multi-action Relief Drops

Reason Non-Sterility

Kilitch Healthcare India Limited NDC 11822-2254-3 D-0308-2024
Class I · High risk Ongoing

Lubricant Gel Drops

Reason Non-Sterility

Kilitch Healthcare India Limited NDC 11822-4540-3 D-0307-2024
Class I · High risk Ongoing

Lubricant Gel Drops

Reason Non-Sterility

Kilitch Healthcare India Limited NDC 11822-4540-5 D-0306-2024